Inventor · disambiguated record
Jian Wu
Also filed as: WU JIAN · WU JIAN-HUI
14 granted patents·21 pending applications·15 citations·filing 2006–2024
86Inventor score
Files withNANJING CHIA TAI TIANQING PHARMACEUTICAL CO LTD8SHANGHAI LUMOSA THERAPEUTICS CO LTD5APPLIED MATERIALS INC3PROGENRA INC3THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIV3
Top patents by PatentIndex Score
35 records- 0190US9717717B1Methods of treating cancer through the inhibition of USP7 and immune system modulationPROGENRA INC·Filed 2016·Granted Aug 1, 2017·9 cites·18 claims
- 0278US10351594B2Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavengingSHANGHAI LUMOSA THERAPEUTICS CO LTD·Filed 2018·Granted Jul 16, 2019·3 cites·2 claims
- 0376US2023312644A1Compounds having triple activities of thrombolysis, antithrombotic and radical scavengingSHANGHAI LUMOSA THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0471US12463085B2Support ring with plasma spray coatingAPPLIED MATERIALS INC·Filed 2023·Granted Nov 4, 2025·0 cites·15 claims
- 0568US2021355163A1Compounds having triple activities of thrombolysis, antithrombotic and radical scavengingSHANGHAI LUMOSA THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0665US8470889B2Hybrid-ionone and curcumin molecules as anticancer agentsWu jian hui·Filed 2009·Granted Jun 25, 2013·2 cites·2 claims
- 0764US9139592B2Modulators of Nrf2 and uses thereofBATIST GERALD·Filed 2011·Granted Sep 22, 2015·1 cites·1 claims
- 0861US12286701B2Preparation method for tungsten sulfide solid lubricating film based on high power impulse magnetron sputteringUNIV TAIZHOU·Filed 2024·Granted Apr 29, 2025·0 cites·13 claims
- 0960US2023302030A1COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPaseTHE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL UNIV·Filed 2023·Application pending·0 cites
- 1059US2025109484A1WEAR-RESISTANT COATING OF AlTiN-WS2 AND PREPARATION METHOD THEREOFUNIV TAIZHOU·Filed 2024·Application pending·0 cites
- 1159US2020055895A1Compounds having triple activities of thrombolysis, antithrombotic and radical scavengingSHANGHAI LUMOSA THERAPEUTICS CO LTD·Filed 2019·Application pending·0 cites
- 1258US2025026773A1Mono-p-toluenesulfonate of axl kinase inhibitor and crystal form thereofNANJING CHIA TAI TIANQING PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1357US2025059159A1Plpro inhibitorsSHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 1456US11594445B2Support ring with plasma spray coatingAPPLIED MATERIALS INC·Filed 2019·Granted Feb 28, 2023·0 cites·11 claims
- 1553US9890193B2Compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging, synthesis, and use thereofSHANGHAI LUMOSA THERAPEUTICS CO LTD·Filed 2015·Granted Feb 13, 2018·0 cites·6 claims
- 1652US2025186444A1Methionine adenosyltransferase 2a heterocyclic inhibitorNANJING CHIA TAI TIANQING PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1751US2023227484A1Pyrimidine compound as axl inhibitorNANJING CHIA TAI TIANQING PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1851US2023295789A1Dense vertically segmented silicon coating for low defectivity in high-temperature rapid thermal processingAPPLIED MATERIALS INC·Filed 2022·Application pending·0 cites
- 1950US11273154B2Azole compounds as ubiquitin-specific protease USP7 inhibitorsPROGENRA INC·Filed 2018·Granted Mar 15, 2022·0 cites·10 claims
- 2050US2024287063A1Methionine adenosyltransferase 2a inhibitorNANJING CHIA TAI TIANQING PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2148US2023321108A1Unit dosage composition of akt inhibitorNANJING CHIA TAI TIANQING PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2247US11434231B2Substituted imidazoles for the treatment of cancerTHE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIV·Filed 2020·Granted Sep 6, 2022·0 cites·30 claims
- 2347US10580694B2Contact structure and method of forming the sameSEMICONDUCTOR MFG INT SHANGHAI CORP·Filed 2018·Granted Mar 3, 2020·0 cites·20 claims
- 2446US2007249432A1Golf club head weight-adjusting structureINVESTECH PREC CASTING CO·Filed 2006·Application pending·0 cites
- 2546US2023271958A1SALT AND CRYSTAL FORM OF DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATENANJING CHIA TAI TIANQING PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2646US2007251077A1Method for manufacturing golf club headsINVESTECH PREC CASTING CO·Filed 2006·Application pending·0 cites
- 2746US2023286979A1Salt of dihydropyrido[2,3-d]pyrimidinone derivative, preparation method therefor, and use thereofNANJING CHIA TAI TIANQING PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2845US10292973B2Covalent irreversible inhibitors of USP7 as anti-cancer agentsPROGENRA INC·Filed 2016·Granted May 21, 2019·0 cites·27 claims
- 2943US2016083388A1Novel modulators of nrf2 and uses thereofTRT PHARMA INC·Filed 2015·Application pending·0 cites
- 3039US2020246365A1Compounds, pharmaceutical compositions and use thereof as inhibitors of ran gtpaseTHE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL UNIV·Filed 2018·Application pending·0 cites
- 3138US10486098B2Method for improving adsorption capability of fixed bed and application method thereof in organic waste gas treatmentNANJING UNIVERSITY OF TECHNOLOGY·Filed 2016·Granted Nov 26, 2019·0 cites·8 claims
- 3238US2022144821A1Akt inhibitorNANJING CHIA TAI TIANQING PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3337US2017273922A1Urea and bis-urea based compounds and analogues thereof useful in the treatment of androgen receptor mediated diseases or disordersTHE ROYAL INST FOR THE ADVACEMENT OF LEARNING/MCGILL UNIV·Filed 2015·Application pending·0 cites
- 3437US2013143933A1Targeted correction of a genetic defect in cancer therapyTRT PHARMA INC·Filed 2012·Application pending·0 cites
- 3529US10844051B2Substituted oxazoles for the treatment of cancerTHE ROYAL INSTITUTION FOR THE ADCANCEMENT OF LEARNING/MCGILL UNIV·Filed 2016·Granted Nov 24, 2020·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →